Predictions
MicroVision Inc
Start price
Target price
Perf. (%)
€6.25
10.06.23
10.06.23
€7.00
10.06.24
10.06.24
-38.41%
10.07.23
10.07.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.25
25.06.23
25.06.23
-
25.06.24
25.06.24
15.66%
09.07.23
09.07.23
Could be worthwhile Investment >10% per year
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€63.18
09.07.22
09.07.22
-
09.07.23
09.07.23
-41.45%
09.07.23
09.07.23
MacroGenics Inc.
Start price
Target price
Perf. (%)
€4.46
29.05.23
29.05.23
-
29.05.24
29.05.24
1.35%
08.07.23
08.07.23
Risky Investment
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.45
11.06.23
11.06.23
-
11.06.24
11.06.24
3.69%
27.06.23
27.06.23
Could be very worthwhile Investment >20% year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.29
11.06.23
11.06.23
-
11.06.24
11.06.24
-2.64%
24.06.23
24.06.23
Could be worthwhile Investment >10% per year
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€60.00
08.09.22
08.09.22
€80.00
31.12.24
31.12.24
35.00%
24.06.23
24.06.23
Could be very worthwhile Investment >20% year
Medigene AG
Start price
Target price
Perf. (%)
€1.92
14.06.23
14.06.23
€2.00
14.06.24
14.06.24
-2.61%
24.06.23
24.06.23
Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.53
22.05.23
22.05.23
-
22.06.23
22.06.23
-17.49%
23.06.23
23.06.23
Could be worthwhile Investment >10% per year
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.40
15.05.23
15.05.23
-
15.05.24
15.05.24
30.00%
12.06.23
12.06.23
Probably not worthwhile Investment
Verastem Inc.
Start price
Target price
Perf. (%)
€13.94
30.05.23
30.05.23
-
30.05.24
30.05.24
-19.06%
11.06.23
11.06.23
Could be very worthwhile Investment >20% year
Poxel S.A.
Start price
Target price
Perf. (%)
€2.49
20.08.22
20.08.22
-
20.08.23
20.08.23
-75.54%
07.06.23
07.06.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€10.23
09.08.22
09.08.22
€14.00
09.08.23
09.08.23
-46.91%
30.05.23
30.05.23
Small cyclical dependencies
Below average Marketposition
Few uniques
Nuwellis Inc.
Start price
Target price
Perf. (%)
€1.26
31.08.22
31.08.22
-
31.08.23
31.08.23
-90.95%
29.05.23
29.05.23
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.79
15.05.23
15.05.23
-
15.05.24
15.05.24
-1.17%
29.05.23
29.05.23
Could be very worthwhile Investment >20% year
Bone Therapeutics S.A.
Start price
Target price
Perf. (%)
€0.27
02.06.22
02.06.22
€0.50
02.06.23
02.06.23
-59.20%
28.05.23
28.05.23
Could be worthwhile Investment >10% per year
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€0.88
17.05.23
17.05.23
-
17.05.24
17.05.24
-25.40%
27.05.23
27.05.23
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.75
22.05.22
22.05.22
-
22.05.23
22.05.23
-78.27%
22.05.23
22.05.23
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€3.19
11.06.22
11.06.22
€1.60
11.06.23
11.06.23
84.40%
19.05.23
19.05.23
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.22
11.03.23
11.03.23
€4.60
11.03.24
11.03.24
18.48%
19.05.23
19.05.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected